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Abstract About half of all patients on home oxygen therapy receive non-continuous oxygen therapy (less than15 h
daily) (NCOT).The goal of NCOT is to improvewell-being during daily activities and to improve sleep quality.The aim of
this study was to evaluate the e¡ect of NCOTon pulmonary symptoms and sleep quality, and to determine whether
patientswith a subjective bene¢cial e¡ectdi¡ered fromthosewithoute¡ect interms of patients’characteristics, utiliza-
tion of oxygen, hospitalization and survival. Furthermore, the relationship between the reported bene¢cial e¡ect of
NCOTon dyspnoea and physical activity during domestic activities was examined.During the period November1994
to July 1995, 254 Danish patients were prescribed oxygen less than 12 h daily or ‘on demand’. Of these patients, 142
(55?9%) answered a questionnaire on hours spent with oxygen and symptomatic e¡ect of oxygen treatment.While on
oxygen, 76?3% of the patients reported improved dyspnoea score (0^10) more than 0?5 points, 78?3% had improved
qualityof life,59?5% improved sleep,48?5% increasedphysical activity,49?3% feltless tiredand 40?0% reportedimproved
thinking. Fifty-seven (43?2%) patients reported both improved dyspnoea and physical activity, whereas seven (5?3%)
patients reported that oxygen had no e¡ect on dyspnoea but a bene¢cial e¡ect on physical activity.Only11 (7?7%) pa-
tients reportedno subjective improvementonoxygen.The subjective e¡ectof NCOTwasnot signi¢cantly associated to
hoursspentwithoxygen, theunderlyingdisease, gender, hospitalizationor survival.Duringdailyactivityandregardlessof
daily number of hours spent with oxygen,NCOT improved well-being in nearly all patients.The most pronounced im-
provementwasreportedondyspnoea, sleep andqualityof life.Very fewpatients sensedimprovedphysical activitywith-
outrelief in breathlessness.r2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1193, available online athttp://www.idealibrary.comon
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Abouthalf of all patients onhome oxygen therapy inU.K.
receive NCOT and this ¢gure is probably even higher
in U.S.A. (1,2). Although the criteria for long-term oxy-
gen therapy (LTOT) are well established, the criteria for
short-term oxygen therapy (NCOT) are less clear (3^5).
NCOT is not aimed on improving survival, but pre-
scribed in order to decrease dyspnoea, increase
exercise capacity and tolerance, and prevent nocturnal
desaturations (3^6).However, the e¡ects of this therapy
are questioned (6^16). Some studies have found thatReceived12 March 2001, accepted in revised form 6 August 2001and
published online 24 October 2001.
Correspondence should be addressed to:Thomas J.Ringbaek,
Moseskraenten17,DK-3140 Aalsgaarde,Denmark.
E-mail: ringbaek@dadlnet.dksupplemental oxygen signi¢cantly improves exercise
tolerance without a¡ecting the dyspnoea (14,16),
whereas other studies found the opposite pattern (9^
12). Studies on NCOT mainly describe the e¡ect during
controlled circumstances, for example during a treadmill
test, and only one small study has evaluated the e¡ect of
NCOT during normal daily activity (17).However, in this
study the bene¢cial e¡ect was not further speci¢ed. In
the present study of patients on NCOT, we evaluated
the e¡ect of therapy on di¡erent symptoms and investi-
gated whether patients with bene¢cial e¡ect di¡ered
from thosewithout subjective e¡ect in terms of patients’
characteristics, utilization of oxygen, hospitalization and
survival. Furthermore, we examined the relationship
between the reported bene¢cial e¡ect of NCOT on
dyspnoea and physical activity during domestic
activities.
TABLE 1. Patients on home oxygen therapy categorized
according to prescribed and used oxygen.Those marked
with bold characters are de¢ned as short-term oxygen
therapy
n=1591 (100%)
Prescribed oxygen
15^24 hdayÿ1 817 (51?4%)
12^14 hdayÿ1 58 (3?6%)
o12 hdayÿ1 82 (5?2%)
‘Asneeded’ 92 (5?8%)
Prescription ismissing
Patientswere using oxygen
o12 hdayÿ1
80 (5?0%)
Patientswere using oxygen
12^24 hdayÿ1
62 (3?9%)
Bothprescribed andused oxygen
according to the patient aremissing
400 (25?1%)
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Collection of information
The Danish Oxygen Register was established in
November 1994 and covers 98% of the Danish popula-
tion. From the patients’ hospital ¢les and GP ¢les, we
achieved information on the cause of hypoxaemia and
smoking status (current smoker, ex-smoker and never
smoker).
During the period, 01.11.94 to 31.07.95, 1591 adult
patients started home oxygen therapy due to cardio-
pulmonary disease or dyspnoea due to extra-thoracic
disease. Although NCOT is not recommended in
Denmark, 254 (16%) patients initiated NCOT, de¢ned
as oxygen prescribed less than 12h daily or ‘on demand’
(Table1).
Within 1month after initiation of NCOT patients re-
ceived a questionnaire by mail on the use of oxygen
(number of hours daily), smoking status (current smoker,
ex-smoker, and never smoker), and on the symptomatic
e¡ect of oxygen therapy (Fig.1). In addition we assessed
breathlessness with and without supplemental oxygen
using standard 10 cm visual analogue scale score (VAS),
rating breathlessness from ‘no breathlessness’ (zero) to
‘extreme breathlessness’ (10 cm).Questions to the patients o
1. How many hours per day do you sp
2. Do you smoke tobacco – “Yes or N
3. Do you have less dyspnoea with ox
4. Does oxygen therapy improve phys
5. Does oxygen therapy help you to th
6. Does oxygen therapy make you less
7. Does oxygen therapy improve your
8. Does oxygen therapy improve your 
9. Mark on the vertical line (10 cm) th
theraphy
 
Extreme breathlessness
  
No
_____________________________
      10                                                     
10. Mark on the vertical line (10 cm) th
theraphy
Extreme breathlessness No
_____________________________
      10                                                     
FIG. 1. Questions to the patients on NCOT.Thenon-responders (44?1%) di¡ered from the respon-
ders by having a higher frequency of lung cancer (52?7%
vs. 23?4%) and a higher 3-month mortality rate (53?2%
vs. 11?8%). The study group comprised 142 responders
with NCOT. Using the answers from questions 3^8
(Fig. 1), and the value 1 for ‘yesFimprovement’, 0 for
‘don’t know’, ‘no improvement’ or no answer, a score ofn NCOT
ent with oxygen?
–
–
–
–
–
–
o”?
ygen therapy  “Yes, No or Don’t know”?
ical activities  “Yes , No or Don’t know”?
ink clear  “Yes, No or Don’t know”?
 tired  “Yes, No or Don’t know”?
 sleep  “Yes, No or Don’t know”?
quality of life  “Yes, No or Don’t know”?
e degree of breathlessness without oxygen
 breathlessness
 
________________  
                     0
 
e degree of breathlessness  with oxygen
 breathlessness
________________  
                        0
TABLE 2. Characteristics of patients onnon-continuous
oxygentherapy
Allpatients (n=142)
Age, years (n=142) 68?9 (9?9)
Female, % (n=142) 44?4
Diagnosis, % (n=141)
COPD 51?1
Cancer 23?4
Cardiacdisease 9?9
Kyphoscoliosis/neuromuscular
disease
5?0
Lung ¢brosis 3?5
Sequelae fromlung tuberculosis 3?5
Other 3?5
Started by a GP, % (n=142) 34?5
Oxygen £ow, lminÿ1 (n=141) 1?7 (1?3)
Mobile system, % (n=142) 21?8
Current smoker, % (n=141) 27?0
GP:General Practitioner.
Age and oxygen £oware presented asmean (SD).
982 RESPIRATORYMEDICINEthe e¡ect of NCOT on symptoms was calculated.
Depending on the symptomatic e¡ect of NCOT,patients
were divided into three groups: (1) scores 4^6 (very
good e¡ect), (2) scores 2 or 3 (good e¡ect), (3) scores 0
or1 (no or some e¡ect).
Data on oxygen systems deliveredwas obtained from
the oxygen suppliers. Mobile oxygen was de¢ned if pa-
tients had cylinders of 2^5 lF if necessary on a stroller.
Liquid oxygenwas not available before August1995.
Vital status was ascertained by the National Health
Services Central Register up to 31.10.98. During
follow-up, 96 (67?6%) deaths were identi¢ed. The
National Board of Health provided information on
hospital admissions up to 31.12.96. Nineteen patients
stopped oxygen therapy before 31.12.96 without a
hospitalization.Timeuntil stopped therapy was included.
Concerning hospitalization, the mean follow-up period
was 197 days. During this period, 107 (75?4%) patients
had at least one admission to hospital. The regional
Ethical Committees and the Data Inspection Board have
approved the study.
There are no Danish guidelines for selecting suitable
patients. However, it is most likely that Danish doctors
are adopting guidelines from U.S.A., U.K. and Australia,
recommending NCOT to patients with symptoms re-
lated to exercise-induced or nocturnal hypoxaemia and
to patients with symptomatic terminal cardio-pulmon-
ary disease without continuous hypoxaemia (7,18,19).
Documentation of a bene¢cial e¡ect of oxygen exceed-
ing a placebo e¡ect is not routine in Denmark before
starting the NCOT.
Statistics
Data analysis and descriptive statistics were performed
using with the Statistical Package for Social Sciences
(SPSS) version 9.0 (SPSS Inc., Chicago, U.S.A.). The
Kaplan^Meier estimate was used to produce survival
and admission rates (time until ¢rst admission), and the
logrank test to testdi¡erencesbetweenCOPD and can-
cer patients. The chi-squared, two sample t-tests and
Mann^Whitney U-tests were used as appropriate to
compare di¡erences between the groups. A two-sided
P-value ofo0?05 was considered signi¢cant.
RESULTS
Characteristics of patients
In general, patients were elderly and a little more than
half (51?1%) of them had COPD (Table 2). The average
£ow of oxygen was 1?7lminÿ1 and only 12?1% of the
patients were prescribed more than 2lminÿ1. Hypox-
aemia, while patients were resting, was documented in
36 (25?4%) patients, whereas a PaO247?3 was recorded
in 13 (9?2%). Among the remaining 93 (65?5%) patients,blood gases were not checked before starting NCOT.
As PaO2 status had no in£uence on the symptomatic
e¡ect of NCOT, in subsequent analyses all patients were
analysed as one group, regardless of presence or absence
of hypoxaemia.
Utilization of oxygen, hospitalization and
survival
On average, patients spent 5?1h daily with oxygen.Nine
patients used oxygen on demand. Very few (5?1%)
patients stated to use oxygen at least 15h daily. The
most common use of oxygen was less than 5h daily
(55?3%).
Themedian timeuntil the ¢rsthospitalizationwas125,
157 and 84 days for all patients, for COPD patients and
cancer patients, respectively. Admission rates were
equal for COPD and cancer patients (P=0?63).
The12-monthmortality rates were 39?4%, 20?8% and
78?8% for all patients, for COPD patients and cancer
patients, respectively. The mortality rates were signi¢-
cantly higher among cancer patients compared with
COPD patients (Po0?001).
Symptomatic e¡ect of NCOT
Decreased dyspnoea and improved quality of life were
the most pronounced symptomatic e¡ects of NCOT
(Fig. 2). Degree of dyspnoea expressed by VAS showed
that the majority (89?3%) scored at least ¢ve points
without oxygen. On oxygen this proportion of patients
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Dyspnoea (n = 135) Physical activity (n = 134) Thinking (n = 135)
Tired (n = 134) Sleep (n = 131) Quality of life (n = 138)
FIG. 2. E¡ect of short-term oxygen therapy on di¡erent
symptoms.Answers to question 3^8 (listed in Fig.1). N=number
of patientswith data.
Missing 0- 1, 99 2- 3, 99 4- 5, 99 6- 7, 99 8- 10
0
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40
Dyspnoea score (with oxygen)
%
Missing 0- 1, 99 2- 3, 99 4- 5, 99 6- 7, 99 8- 10
0
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%
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- 10 to 8
0
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- 3.9 to - 2
- 1.9- 0
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FIG. 3. Dyspnoea scorewithout oxygen, with oxygen and dif-
ference between dyspnoea score (with^without oxygen) ac-
cording to a visual analogue scale (0^10).
NON-CONTINUOUSHOMEOXYGENTHERAPY 983was reduced to 50% (Fig. 3).Thus, 76?3% of the patients
improved their dyspnoea score more than 0?5 points,
which is considered as clinically relevant (20).
On oxygen therapy, 57 (43?2%) of the patients
reported both improvements in dyspnoea and physical
activity, whereas 43 (32?6%) patients reported bene¢cial
e¡ect on dyspnoea without an improvement in physical
activity. Only seven (5?3%) patients reported improved
physical activity without any bene¢cial e¡ect on
breathlessness. Twenty-¢ve (18?9%) patients reported
no e¡ect on either breathlessness or physical activity
and the remaining 10 patients had not answered both
questions.
Improved sleep was reported in 78 (59?5%) of the
patients. A utilization of oxygen at least 7 h daily was
more common among these patients compared to
patients without improved sleep (71% vs. 52%;P=0?03).
Only11 (7?7%) patients hadno subjective e¡ect and 23
(16?2%) had ‘some or no e¡ect’ (group 3), 44 (31?0%) had
‘good e¡ect’ (group 2) and 75 (52?8%) had ‘very good
e¡ect’ (group1) of oxygen therapy.Comparison between patientswith very
goode¡ect (group1) andthosewith some or
no e¡ect of NCOT (group 3)
Patients with no or some e¡ect of NCOT (group 3) had,
as compared with patients with very good e¡ect of
NCOT (group 1), a signi¢cantly lower dyspnoea
score (without oxygen) [mean di¡erence: 1?4 (95% CI:
0?2^2?6)]. Also, both groups did not di¡er in terms of
age, gender, diagnosis, delivered mobile oxygen,
prescribed oxygen £ow, spent hours with oxygen,
median time until hospitalization, 12- and 24-month
984 RESPIRATORYMEDICINEmortalityrates, and smoking, although therewas a trend
towards a higher proportion of current smokers in group
3 (40?9%) comparedwith group1 (27?0%) (P=0?2).
DISCUSSION
NCOT is widely prescribed in Denmark, comprising
16^41% of all initiated home treatments with oxygen,
andmost patients are treated with oxygen for at least 1
year.NCOT is aimed on improving well-being, and in our
study all but11patients (92?3%) had at least some subjec-
tive e¡ect. This is in line with the results of a previous
study ¢nding bene¢cial e¡ect of oxygen in 44 of 45
patients on NCOT (17). A little more than half of our
patients (52?8%) reported an e¡ect on several subjective
parameters, particularly decreased breathlessness and
increased quality of life. This marked bene¢cial e¡ect of
NCOT is surprising because oxygen therapy is encum-
bered with several disadvantages. In a study from The
Netherlands, inconvenience during LTOTwas reported
from 95% of the patients (21). An explanation might be
that theyhave studiedpatients on LTOTwhererestricted
autonomy, noise from oxygen concentrators and nose
complaints are more likely to occur than in our patients
on NCOT. In addition, patients on NCOT are probably
selected due to the symptomatic e¡ect of oxygen and
are probably highly motivated for this treatment. An-
other disadvantage of oxygen therapy is the weight of
mobile oxygen cylinders. If the patient has to carry the
gas cylinder, the exercise tolerance decreases by about
10% and dyspnoea score increases by 10^20% (8,15,22).
Supporting a bene¢cial e¡ectof oxygen, despite carrying
the oxygen cylinder, two studies suggest that the e¡ect
of placebo counterbalances the burden of carrying the
gas cylinder (10,11,14), and oxygen improves exercise
tolerance and symptoms additionally (15,22).
Calverley has recently suggested that some patients
with supplemental oxygen choose to exercise to the
same level of breathlessness as previously but, because
they are either ¢tter or less distressed, they cover a
greater physical activity. Alternatively, they keep the
same exercise activitybut experience lessbreathlessness
(1).Our data, focusing on daily activity, showed that the
latter explanation was common (32?6% of the patients),
and that very few (5?3%) patients report a greater physi-
cal activity but no improvement on breathlessness while
on NCOT.
The subjective e¡ect of oxygen therapy found in our
study could well be attributed to a placebo e¡ect.There
is growing evidence that placebo (sham oxygen) relieves
dyspnoea (12^14,23^25) and improves exercise perfor-
mance (12,14,23). However, most studies have found
oxygen superior to placebo in decreasing dyspnoea and
increasing exercise tolerance (9,12,14^16,22,23,26,27).The majority of our patients had sleep disturbances
that a¡ected quality of life. This is in line with the IPPB
and NOTTstudies of COPD patients ¢nding a very high
score (impairment) for these domains (28,29). Nearly
60% of our patients reported improvement in sleep qual-
ity. Whether supplemental oxygen improves quality of
sleep is not clear (30^32). In patients with nocturnal
hypoxaemia supplemental oxygen reduces or alleviates
hypoxaemia, but does not modify the evolution of
pulmonary haemodynamics and seems not to improve
survival (6).
About 40% of our patients reported improvedmental
activity.This improvementmaybe attributed to aplacebo
e¡ect, because a placebo controlled studyof hypoxaemic
COPD patients failed to ¢nd a bene¢cial e¡ect of oxygen
on a short-term basis (33).On the other hand, continu-
ous oxygen therapy seems to improve mental activity
(34,35).
Fatigue is a prominent symptom associated with
severe lung disease.Half of our patients felt less tired on
NCOT.Whether this is due to oxygen therapyor placebo
is unclear, because so far, no placebo-controlled studies
have examined the e¡ect of oxygen on tiredness, fatigue
or exhaustion.
In our study, no association was found between the
subjective e¡ect and the utilization of oxygen. The
explanation might be that NCOT is not always used to
treat continuous symptoms, for example some patients
use oxygen to treat nocturnal desaturations, while
others only use oxygen during exercise or during attacks
of breathlessness.
The goal of NCOT is to improve well-being during
daily activity. Judging by the patients’ own reports, this
goal was met by 92% of our patients who were pre-
scribed NCOT. However, the bene¢t seemed not to be
a¡ected by either time spent with oxygen, the underly-
ing disease or gender. Therefore, randomized, placebo-
controlled studies are warranted in well-de¢ned patient
groups in order to separate the e¡ectof oxygen from the
e¡ect of placebo during daily activities.
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